Impact of Symbiotic Administration on Intestinal Function of Head and Neck Patients Surgically Treated

Intestinal Function of Patients With Uper Air and Digestive Neoplasia Submitted to Surgical Treatment: Symbiotic Use Impact

The purpose of this study is to determine whether the symbiotic use in patients with head and neck cancer impact on intestinal function after surgical treatment.

The study will be conducted offering the patients symbiotic product twice a day for seven days after the surgical treatment. Patients will be monitored for the number of stools, stools consistency, abdominal pain and gas overproduction.

Inclusion Criteria:

• head and neck cancer with primary surgical treatment, enteral nutrition by enteral tube.

Exclusion Criteria:

• three months antibiotic use earlier the surgery, recently radiotherapy or quimiotherapy, inflammatory bowel disease.